Loading clinical trials...
Loading clinical trials...
Multicenter Pivotal Study of the Velocity™ Percutaneous Arterio-Venous Fistula System
Conditions
Interventions
Velocity Percutaneous Arteriovenous Fistula
Locations
10
United States
Trinity Research Group
Dothan, Alabama, United States
West Coast Kidney Institute Concord
Concord, California, United States
Apex Research
Riverside, California, United States
Vascular and Embolization Specialists
Cocoa, Florida, United States
Azura Vascular Care Jacksonville
Jacksonville, Florida, United States
Surgical Specialists of Charlotte
Charlotte, North Carolina, United States
Start Date
October 21, 2025
Primary Completion Date
September 1, 2026
Completion Date
September 1, 2030
Last Updated
January 30, 2026
NCT07547098
NCT07232537
NCT06278207
NCT07493642
NCT07241390
NCT05728216
Lead Sponsor
Venova Medical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions